Merlin MD

Merlin MD is a medical device company headquartered in Singapore that specializes in the development of advanced endovascular implants for the treatment of cerebral aneurysms. The company's core innovation is its proprietary 3D-Pore technology, which is utilized in the design of its flagship Merlin stent system. This technology provides a specialized scaffolding structure intended to optimize flow diversion, effectively redirecting blood flow away from the aneurysm to promote thrombosis and vessel healing. As an early pioneer in the flow diversion space, Merlin MD aimed to provide a safer and more effective alternative to traditional surgical clipping and endovascular coiling. In 2011, the company merged with the German medical technology firm Aachen Resonance to expand its global reach and product portfolio.